Literature DB >> 16642558

Metaplastic carcinoma with extensive chondroid differentiation in the breast (chondroid carcinoma).

Yee-Jeong Kim1, Hyo-Seob Shim, Hyde Lee, Woo-Hee Jung.   

Abstract

Metaplastic breast carcinoma is very rare, and metaplastic carcinoma with chondroid differentiation is even rarer. Here, we report a case of metaplastic carcinoma with extensive chondroid differentiation mimicking chondrosarcoma that was challenging to diagnose. The tumor was characterized by an abundant chondromyxoid matrix. The definitive area of classic invasive ductal carcinoma was minimal. The peripheral portion of the tumor showed increased cellularity with pleomorphism and definitive invasive growth. Tumor cells in the chondrosarcomatous areas were diffusely immunoreactive for S-100 protein, patchy positive for cytokeratin, but negative for epithelial membrane antigen (EMA). Tumor cells in carcinomatous areas were diffusely positive for cytokeratin, S-100 protein, and patchy positive for EMA. In both areas, tumor cells were negative for smooth muscle actin (SMA) and CD34, while oncoprotein p53 was overexpressed. When pathologists encounter breast tumors with chondroid differentiation, careful sampling and immunohistochemistry for cytokeratin and SMA are most helpful to differentiate metaplastic carcinoma from malignant phyllodes tumor and malignant adenomyoepithelioma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16642558      PMCID: PMC2687638          DOI: 10.3349/ymj.2006.47.2.259

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  8 in total

1.  Metaplastic breast carcinoma: pathology and clinical outcome.

Authors:  Roberto Bellino; Riccardo Arisio; Francesco D'Addato; Rossella Attini; Antonio Durando; Saverio Danese; Elena Bertone; Ruggero Grio; Marco Massobrio
Journal:  Anticancer Res       Date:  2003 Jan-Feb       Impact factor: 2.480

2.  Metaplastic carcinoma of the breast with osteocartilaginous heterologous elements.

Authors:  C Chhieng; M Cranor; M E Lesser; P P Rosen
Journal:  Am J Surg Pathol       Date:  1998-02       Impact factor: 6.394

3.  p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma.

Authors:  Meryem M Koker; Celina G Kleer
Journal:  Am J Surg Pathol       Date:  2004-11       Impact factor: 6.394

4.  Carcinoma of the breast with pseudosarcomatous metaplasia.

Authors:  M W Kaufman; J R Marti; H S Gallager; J L Hoehn
Journal:  Cancer       Date:  1984-05-01       Impact factor: 6.860

5.  Benign myoepithelial tumors of the breast have immunophenotypic characteristics similar to metaplastic matrix-producing and spindle cell carcinomas.

Authors:  Nikolay K Popnikolov; Alberto G Ayala; Kerry Graves; Zoran Gatalica
Journal:  Am J Clin Pathol       Date:  2003-08       Impact factor: 2.493

6.  Demonstration of estrogen receptor by immunohistochemical staining in paraffin sections of breast carcinoma.

Authors:  W I Yang; I J Choi; H O Kim; K S Lee
Journal:  Yonsei Med J       Date:  1991-06       Impact factor: 2.759

7.  An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast.

Authors:  Barbara Dunne; Andrew H S Lee; Sarah E Pinder; Jane A Bell; Ian O Ellis
Journal:  Hum Pathol       Date:  2003-10       Impact factor: 3.466

8.  Malignant phyllodes tumor of the breast with predominant chondrosarcomatous differentiation.

Authors:  Francisco Vera-Sempere; Ana García-Martínez
Journal:  Pathol Res Pract       Date:  2003       Impact factor: 3.250

  8 in total
  2 in total

1.  A Case of Metaplastic Breast Cancer with Prolonged Response to Single Agent Liposomal Doxorubicin.

Authors:  Lamya Hamad; Thaer Khoury; Karen Vona; Jill Nestico; Mateusz Opyrchal; Kilian E Salerno
Journal:  Cureus       Date:  2016-01-11

Review 2.  Pleural chondroid metaplasia in a background of IgG4 plasma cell rich chronic inflammatory infiltrate: report of a rare case with review of literature.

Authors:  M Spinelli; A Datta; M A Montero Fenandez; P Viola
Journal:  Pathologica       Date:  2019-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.